These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6106128)

  • 21. Perspectives on occupational exposure to antineoplastic drugs.
    Fishbein L
    Arch Geschwulstforsch; 1987; 57(3):219-48. PubMed ID: 3304187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of immune system contribution to efficiency of antitumor cytostatic therapy].
    Stakheeva MN; Kzhyshkowska YG; Buldakov MA; Cherdyntseva NV
    Vopr Onkol; 2015; 61(4):546-55. PubMed ID: 26571821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
    Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses.
    DeJoy DM; Smith TD; Woldu H; Dyal MA; Steege AL; Boiano JM
    J Occup Environ Hyg; 2017 Jul; 14(7):485-493. PubMed ID: 28326998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage.
    Buschini A; Villarini M; Feretti D; Mussi F; Dominici L; Zerbini I; Moretti M; Ceretti E; Bonfiglioli R; Carrieri M; Gelatti U; Rossi C; Monarca S; Poli P
    Occup Environ Med; 2013 Nov; 70(11):789-94. PubMed ID: 24143019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytostatic effect of neuroleptics.
    Neumann NU
    Acta Psychiatr Scand; 1988 Jul; 78(1):109. PubMed ID: 2902737
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of genotoxicity induced by exposure to antineoplastic drugs in lymphocytes of oncology nurses and pharmacists.
    El-Ebiary AA; Abuelfadl AA; Sarhan NI
    J Appl Toxicol; 2013 Mar; 33(3):196-201. PubMed ID: 21935972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of genotoxic effects in nurses handling cytostatic drugs.
    Ladeira C; Viegas S; Pádua M; Gomes M; Carolino E; Gomes MC; Brito M
    J Toxicol Environ Health A; 2014; 77(14-16):879-87. PubMed ID: 25072720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of adherence to safe handling practices for antineoplastic drugs: A survey of hospital nurses.
    Silver SR; Steege AL; Boiano JM
    J Occup Environ Hyg; 2016; 13(3):203-12. PubMed ID: 26556549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor fighter.
    Kiser K
    Minn Med; 2012 Jan; 95(1):16-9. PubMed ID: 22355905
    [No Abstract]   [Full Text] [Related]  

  • 32. [Urinary excretion of mutagens and cisplatin among the nursing staff at a medical oncology department exposed to cytostatic drugs].
    Clonfero E; Granella M; Gori GP; Venier P; Levis AG; Morandi P; Bartolucci GB; Saia B
    Med Lav; 1989; 80(5):412-9. PubMed ID: 2622413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hygienic examination and follow-up of occupational risks of handling cytostatic drugs at an oncology unit.
    Medková J
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():241-53. PubMed ID: 1837667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The possible mutagenic effects of cytostatics on nurses in an oncology department].
    Bastholt L
    Ugeskr Laeger; 1984 Aug; 146(35):2610-3. PubMed ID: 6515872
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute symptoms associated with antineoplastic drug handling among nurses.
    Valanis BG; Vollmer WM; Labuhn KT; Glass AG
    Cancer Nurs; 1993 Aug; 16(4):288-95. PubMed ID: 8402605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs].
    Xu SJ; Wang JX; Yang DP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):119-20. PubMed ID: 12839665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs.
    Anwar WA; Salama SI; el Serafy MM; Hemida SA; Hafez AS
    Mutagenesis; 1994 Jul; 9(4):315-7. PubMed ID: 7968572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Work practice and some adverse health effects in nurses handling antineoplastic drugs.
    Krstev S; Perunicić B; Vidaković A
    Med Lav; 2003; 94(5):432-9. PubMed ID: 14619181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.
    Sessink PJ; Bos RP
    Drug Saf; 1999 Apr; 20(4):347-59. PubMed ID: 10230582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Handling of injectable antineoplastic agents.
    Knowles RS; Virden JE
    Br Med J; 1980 Aug; 281(6240):589-91. PubMed ID: 7427382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.